Findings indicate favorable safety profile for CL2020 Muse cell-based therapeutic for amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by progressive loss of motor functions, which eventually leads to death within five years of its onset. This disease causes weakness and atrophy ...
Feb 1, 2024
0
0